On Friday, April 10, at 10:00 a.m. ET, the Bipartisan Commission on Biodefense at the Atlantic Council will host its latest meeting, examining how biodefense technology innovators are achieving success and taking on challenges in an ever-changing threat environment.
Biotechnology has accelerated at a rapid pace, driven in part by federal investment and policy. Advances in biological sciences create new opportunities for addressing biological events, and the public and private sectors at all levels have a role to play in bolstering these efforts. This meeting of the commission will discuss the biological threat to food and agriculture, and the international perspective on the threat. The discussions will also touch upon the state of biotechnology innovation and federal regulation, research, and development activities.
New policy: In-person attendees will be required to show photo ID upon arrival, and no on-site registration will be permitted.
Please complete the form below to register for this event.
Speakers
Agenda
10:00–10:10 a.m. | Welcome remarks
Fred Upton
Commissioner,
Bipartisan Commission on Biodefense,
Atlantic Council
Tom Ridge
Co-Chair,
Bipartisan Commission on Biodefense,
Atlantic Council
10:10–10:55 a.m. | Panel one: In the big house
A Member of Congress will provide their views on biodefense, public health preparedness and innovations in medical countermeasure development.
Speaker
The Hon. Diana DeGette
United States Representative (D-CO-1);
Ranking Member,
Subcommittee on Health, House Committee on Energy and Commerce
10:55 a.m.–12:25 p.m. | Panel two: Great Lakes vigilance
Speakers will address the biological threat landscape.
Speakers
Jennifer Runyan
Special Agent in Charge,
Detroit Field Office, Federal Bureau of Investigation
Natasha Bagdasarian
Chief Medical Executive for the State of Michigan
12:25–1:10 p.m. | Lunch
Join us for our lunch break.
1:10–2:30 p.m. | Panel three: Pure science
Speakers will discuss policy and resource needs for federal investment in biotechnology, regulation of medical countermeasures and other products, and public-private partnerships for biodefense research and development.
Speakers
Peter Marks
Senior Vice President, Molecule Discovery,
Eli Lilly;
Former Director,
Center for Biologics Evaluation and Research, Food and Drug Administration
Anand K. Parekh
Chief Health Policy Officer,
School of Public Health, University of Michigan
2:30–2:45 p.m. | Break
Break in programming.
2:45–4:00 p.m. | Panel four: Arsenal of innovation
Speakers will highlight private sector successes and challenges in the current biodefense research, development, and manufacturing landscape, lessons learned for future innovation, and areas where government assistance could help elevate industry activities in this sector.
Speakers
Kevin Esch
Executive Vice President,
Research and Development, Zoetis
Paul Williams
Senior Vice President,
Products Business, Emergent Biosolutions
Mary Retzlaff
Chief Science Officer,
Ambient Biosciences
Stephen Rapundalo
President and Chief Executive Officer,
Michigan Biosciences Industry Association
4:00–4:05 p.m. | Closing remarks
Fred Upton
Commissioner,
Bipartisan Commission on Biodefense,
Atlantic Council
Stay connected
explore the programs
The Bipartisan Commission on Biodefense at the Atlantic Council provides a comprehensive assessment of the state of US biodefense and recommends changes to policy and law that strengthen national biodefense while optimizing biodefense resources.
The Scowcroft Center for Strategy and Security works to develop sustainable, nonpartisan strategies to address the most important security challenges facing the United States and the world.
Atlantic Council TV
Watch this event and more content on ACTV
Follow the conversations shaping our world. Available on all major platforms.
Follow the conversation on X with @Biodefensecomm, @ACScowcroft, @AtlanticCouncil